Inventor · disambiguated record
Stephane Bancel
Also filed as: BANCEL STEPHANE · BANCEL STÉPHANE
32 granted patents·33 pending applications·2,373 citations·filing 2007–2024
98Inventor score
Files withMODERNATX INC30MODERNA THERAPEUTICS INC25modeRNA Therapeutics5SCHRUM JASON P2COMMISSARIAT ENERGIE ATOMIQUE1
Top patents by PatentIndex Score
65 records- 0199US10772975B2Modified Polynucleotides for the production of biologics and proteins associated with human diseaseMODERNATX INC·Filed 2017·Granted Sep 15, 2020·37 cites·11 claims
- 0299US9675668B2Modified polynucleotides encoding hepatitis A virus cellular receptor 2MODERNA THERAPEUTICS INC·Filed 2013·Granted Jun 13, 2017·109 cites·14 claims
- 0399US9597380B2Terminally modified RNAMODERNATX INC·Filed 2013·Granted Mar 21, 2017·143 cites·13 claims
- 0499US9587003B2Modified polynucleotides for the production of oncology-related proteins and peptidesMODERNA THERAPEUTICS INC·Filed 2016·Granted Mar 7, 2017·67 cites·19 claims
- 0599US9572896B2In vivo production of proteinsMODERNA THERAPEUTICS INC·Filed 2015·Granted Feb 21, 2017·75 cites·11 claims
- 0699US9572897B2Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteinsMODERNA THERAPEUTICS INC·Filed 2016·Granted Feb 21, 2017·65 cites·19 claims
- 0799US9504734B2Modified polynucleotides for the production of nuclear proteinsMODERNA THERAPEUTICS INC·Filed 2015·Granted Nov 29, 2016·56 cites·19 claims
- 0899US9254311B2Modified polynucleotides for the production of proteinsMODERNA THERAPEUTICS INC·Filed 2013·Granted Feb 9, 2016·126 cites·14 claims
- 0999US9221891B2In vivo production of proteinsMODERNA THERAPEUTICS INC·Filed 2013·Granted Dec 29, 2015·113 cites·13 claims
- 1099US9181319B2Engineered nucleic acids and methods of use thereofMODERNA THERAPEUTICS INC·Filed 2014·Granted Nov 10, 2015·94 cites·9 claims
- 1198US9428535B2Modified nucleosides, nucleotides, and nucleic acids, and uses thereofmodeRNA Therapeutics·Filed 2012·Granted Aug 30, 2016·113 cites·25 claims
- 1298US8999380B2Modified polynucleotides for the production of biologics and proteins associated with human diseasemodeRNA Therapeutics·Filed 2013·Granted Apr 7, 2015·258 cites·16 claims
- 1398US8822663B2Engineered nucleic acids and methods of use thereofSCHRUM JASON P·Filed 2011·Granted Sep 2, 2014·387 cites·4 claims
- 1498US8710200B2Engineered nucleic acids encoding a modified erythropoietin and their expressionSCHRUM JASON P·Filed 2012·Granted Apr 29, 2014·382 cites·14 claims
- 1597US9878056B2Modified polynucleotides for the production of cosmetic proteins and peptidesMODERNATX INC·Filed 2013·Granted Jan 30, 2018·33 cites·9 claims
- 1697US9814760B2Modified polynucleotides for the production of biologics and proteins associated with human diseaseMODERNATX INC·Filed 2015·Granted Nov 14, 2017·15 cites·12 claims
- 1797US9464124B2Engineered nucleic acids and methods of use thereofMODERNA THERAPEUTICS INC·Filed 2014·Granted Oct 11, 2016·188 cites·17 claims
- 1896US9782462B2Modified polynucleotides for the production of proteins associated with human diseaseMODERNA THERAPEUTICS INC·Filed 2016·Granted Oct 10, 2017·7 cites·19 claims
- 1996US9447164B2Engineered nucleic acids and methods of use thereofMODERNA THERAPEUTICS INC·Filed 2015·Granted Sep 20, 2016·15 cites·13 claims
- 2095US10925935B2Terminally Modified RNAMODERNA TX INC·Filed 2018·Granted Feb 23, 2021·18 cites·37 claims
- 2195US10155029B2Terminally modified RNAMODERNATX INC·Filed 2017·Granted Dec 18, 2018·12 cites·15 claims
- 2295US10022425B2Engineered nucleic acids and methods of use thereofMODERNATX INC·Filed 2016·Granted Jul 17, 2018·13 cites·25 claims
- 2395US9937233B2Engineered nucleic acids and methods of use thereofMODERNATX INC·Filed 2016·Granted Apr 10, 2018·12 cites·34 claims
- 2495US9827332B2Modified polynucleotides for the production of proteinsMODERNA THERAPEUTICS INC·Filed 2015·Granted Nov 28, 2017·7 cites·33 claims
- 2593US11845772B2Ribonucleic acid purificationMODERNATX INC·Filed 2022·Granted Dec 19, 2023·1 cites·16 claims
- 2693US10858647B2Removal of DNA fragments in mRNA production processMODERNATX INC·Filed 2018·Granted Dec 8, 2020·8 cites·11 claims
- 2791US9828416B2Modified polynucleotides for the production of secreted proteinsMODERNATX INC·Filed 2015·Granted Nov 28, 2017·3 cites·24 claims
- 2890US10138507B2Manufacturing methods for production of RNA transcriptsMODERNATX INC·Filed 2014·Granted Nov 27, 2018·6 cites·9 claims
- 2989US11377470B2Ribonucleic acid purificationMODERNATX INC·Filed 2014·Granted Jul 5, 2022·5 cites·17 claims
- 3089US2025170228A1Terminally modified rnaMODERNATX INC·Filed 2024·Application pending·0 cites
- 3187US10751386B2Engineered nucleic acids and methods of use thereofMODERNATX INC·Filed 2018·Granted Aug 25, 2020·2 cites·14 claims
- 3284US10077439B2Removal of DNA fragments in mRNA production processMODERNATX INC·Filed 2014·Granted Sep 18, 2018·3 cites·11 claims
- 3381US2021115101A1Modified polynucleotides for the production of proteins associated with human diseaseMODERNATX INC·Filed 2019·Application pending·0 cites
- 3479US2022273766A1Engineered nucleic acids and methods of use thereofMODERNATX INC·Filed 2021·Application pending·0 cites
- 3579US2021299278A1Modified polynucleotides for the production of biologics and proteins associated with human diseaseMODERNATX INC·Filed 2020·Application pending·0 cites
- 3676US12023371B2Terminally modified RNAMODERNATX INC·Filed 2020·Granted Jul 2, 2024·0 cites·16 claims
- 3772US2018086807A1Modified polynucleotides for the production of proteins associated with human diseaseMODERNATX INC·Filed 2017·Application pending·0 cites
- 3871US2019240351A1Modified polynucleotides for the production of proteinsMODERNATX INC·Filed 2017·Application pending·0 cites
- 3970US2015051268A1Methods of increasing the viability or longevity of an organ or organ explantMODERNA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4069US2018170990A1Modified polynucleotides for the production of nuclear proteinsMODERNATX INC·Filed 2017·Application pending·0 cites
- 4168US2021230578A1Removal of dna fragments in mrna production processMODERNATX INC·Filed 2020·Application pending·0 cites
- 4267US2017028085A1Modified polynucleotides for the production of nuclear proteinsMODERNATX INC·Filed 2016·Application pending·0 cites
- 4365US2019030129A1Engineered nucleic acids and methods of use thereofMODERNATX INC·Filed 2018·Application pending·0 cites
- 4464US2013123481A1Modified nucleosides, nucleotides, and nucleic acids, and uses thereofmodeRNA Therapeutics·Filed 2013·Application pending·0 cites
- 4561US2018318446A1Engineered nucleic acids and methods of use thereofMODERNATX INC·Filed 2018·Application pending·0 cites
- 4660US2019085368A1Manufacturing methods for production of rna transcriptsMODERNATX INC·Filed 2018·Application pending·0 cites
- 4759US2014343129A1Modified nucleic acids, and acute care uses thereofMODERNA THERAPEUTICS INC·Filed 2012·Application pending·0 cites
- 4858US2016271272A1Engineered nucleic acids and methods of use thereofMODERNA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4956US2022273555A1Modified polynucleotides for the production of membrane proteinsMODERNATX INC·Filed 2020·Application pending·0 cites
- 5056US2017056528A1Modified nucleosides, nucleotides, and nucleic acids, and uses thereofMODERNA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Showing the top 50 of 65 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Stephane Bancel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →